Algert Global’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.8M | Buy |
124,730
+52,430
| +73% | +$755K | 0.04% | 661 |
|
|
2025
Q1 | $499K | Buy |
+72,300
| New | +$499K | 0.01% | 916 |
|
|
2022
Q4 | – | Sell |
-11,770
| Closed | -$14K | – | 1318 |
|
|
2022
Q3 | $14K | Sell |
11,770
-28,800
| -71% | -$34.3K | ﹤0.01% | 1153 |
|
|
2022
Q2 | $68K | Buy |
40,570
+6,490
| +19% | +$10.9K | 0.01% | 1141 |
|
|
2022
Q1 | $84K | Buy |
+34,080
| New | +$84K | 0.01% | 1114 |
|
|
2021
Q3 | – | Sell |
-12,030
| Closed | -$119K | – | 1089 |
|
|
2021
Q2 | $119K | Buy |
+12,030
| New | +$119K | 0.04% | 386 |
|
|
2021
Q1 | – | Sell |
-27,340
| Closed | -$131K | – | 548 |
|
|
2020
Q4 | $131K | Hold |
27,340
| – | – | 0.04% | 366 |
|
|
2020
Q3 | $110K | Hold |
27,340
| – | – | 0.03% | 355 |
|
|
2020
Q2 | $125K | Sell |
27,340
-610
| -2% | -$2.79K | 0.04% | 365 |
|
|
2020
Q1 | $91K | Buy |
+27,950
| New | +$91K | 0.04% | 359 |
|